Company Overview

Company name: Xanthic Biopharma
Also known as: Xanthic
Description: Manufacturer of cannabis and cannabis-infused products created to eliminate inconvenience, messiness and stigma related to the smoking of Marijuana while delivering the desired physical and emotional benefits via cannabis-infused alternatives. The company’s products include non-combustible cannabis and cannabis infused drink powders, enabling customers to reduce nausea and vomiting during chemotherapy, improve appetite in people with HIV/AIDS and reduce chronic pain and muscle spasms.
Year founded: 1968
Parent company: Green Growth Brands
Industry: Healthcare | Group: Pharmaceuticals and Biotechnology | Code:
City: Torronto
State: Ontario
Country: Canada
Region: Americas

Financial Highlights

Start up capital raised (USD Million): 1.98
Business status: Generating Revenue
Ownership: Acquired/Merged (Operating Subsidiary)
Revenue (USD Million): 0.00
Gross profit (USD Million):
Net income (USD Million) -2.23
Enterprise value:
Earnings before interest, tax, depreciation and amortization (EBITDA): -2.22
Fiscal period: FY 2018
Financing Status: The company was acquired by Green Growth Brands through a reverse merger, resulting in the combined entity trading on the Canadian Securities Exchange under the ticker symbol GGB on November 9, 2018.
Number of active investors:
Profile last updated: 20-Nov-2018
Last known valuation:
Last known valuation date: